BioSpace News Archive

Maryland Life Sciences, a division of the Maryland Tech Council, hosted the successful 2022 Bio Innovation Conference October 3-4 in Bethesda, Maryland.

Latest Study on “Transthyretin Amyloidosis Treatment Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030”.

According to Nova one advisor, the global Monkeypox Vaccine And Treatment market size is expected to hit around USD 214.79 million by 2030 from valued at USD 85.43 million in 2022 and growing at a CAGR of 10.26% from 2022 to 2030.

RealTime Software Solutions, LLC has partnered with Aspen Insights to integrate a best-in-class EMR/EHR patient identification technology into RealTime’s world-class Clinical Trial Management System (CTMS).

Gemina Laboratories Ltd. is pleased to announce that it has entered into agreement with International Point of Care, Inc, for the manufacturing of its Legio XTM COVID-19 Rapid Antigen Test.

Octapharma announced today the results from the ProDERM study on the efficacy and safety of octagam® 10% [Immune Globulin Intravenous (Human)], in adult dermatomyositis (DM) patients have been published in the New England Journal of Medicine (Aggarwal R et al. “Efficacy and safety of intravenous immunoglobulin in dermatomyositis”).

Parallel ENT & Allergy Partners has added a second state to its roster of high-quality, innovative ENT and allergy partners with the addition of Grand Rapids ENT.

NICO Corporation announced that enrollment is now complete for the ENRICH randomized controlled trial.

The National Kidney Foundation has launched a new animated video series aimed at educating people on their chronic kidney disease risk.

Galapagos NV (Euronext & NASDAQ: GLPG) will present data at the United European Gastroenterology(UEG)Week2022,taking place from8-11 October 2022. Several Galapagos driven presentationswill be showcased, including new post hoc analyses of the SELECTION study, which investigated the safety and efficacy of Jyseleca®(filgotinib).